TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1547767

Group type: EXPERIMENTAL
Intervention: Brand-name phenytoin (PHT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Generic phenytoin (PHT)
Number of subjects: 10
Study: 3870624

Group type: EXPERIMENTAL
Intervention: Ticlopidine (500 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CU membrane (Gambro 120 M)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CA membrane (Cordis Dow 3500)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CU placebo session
Number of subjects: 0
Study: 30318584

Group type: EXPERIMENTAL
Intervention: Standard care (fluid resuscitation)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Fluid boluses
Number of subjects: 76
Study: 30078554

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 64)
Number of subjects: 90
Study: 27485050

Group type: EXPERIMENTAL
Intervention: Vitamin D levels at 12-20 weeks
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Vitamin D levels at 34-36 weeks
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Vitamin D levels
Number of subjects: 117
Study: 26180145

Group type: EXPERIMENTAL
Intervention: Inspiratory and expiratory muscle training (IEMT)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Sham IEMT (Control)
Number of subjects: 109
Study: 23106834

Group type: EXPERIMENTAL
Intervention: Endometrial scratching
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo procedure
Number of subjects: 105
Study: 21116072

Group type: EXPERIMENTAL
Intervention: Distal protection (DP) device (Filtrap, Nipro, Japan) during primary PCI
Number of subjects: 36

Group type: COMPARATOR
Intervention: Stenting without distal protection (non-DP group)
Number of subjects: 36
Study: 18682445

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study: 16819678

Group type: EXPERIMENTAL
Intervention: Polyethylene on zirconia (n = 15)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: CoCr on CoCr (n = 9)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Alumina on alumina (n = 11)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Osteoarthritis control group
Number of subjects: 37
Study: 12654171

Group type: EXPERIMENTAL
Intervention: Marine oil (MO) 600 mg/d providing 150 mg DHA + 30 mg EPA for 6 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (600 mg sunflower oil/d)
Number of subjects: 20
Study: 11165585

Group type: EXPERIMENTAL
Intervention: Elevated umbilical venous cord blood plasma IL‐6 concentrations (≥10 pg/mL)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Normal umbilical venous cord blood plasma IL‐6 concentrations (<10 pg/mL)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: IL‐6 as a screening test for funisitis
Number of subjects: 92
Study: 9553402

Group type: EXPERIMENTAL
Intervention: Daily oral supplementation with vitamin C, E, and beta-carotene for 21 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 7997808

Group type: EXPERIMENTAL
Intervention: Tissue polypeptide-specific (TPS) antigen
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: CA 125 antigen
Number of subjects: 85

Group type: COMPARATOR
Intervention: Combination of TPS and CA 125
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: TPS and CA 125 during therapy and follow-up
Number of subjects: 85
Study: 3041630

Group type: EXPERIMENTAL
Intervention: cefpimizole
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: cefotaxime
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: aqueous procaine penicillin G (APPG) with 1 g of oral probenecid
Number of subjects: 116
Study: 30457698

Group type: EXPERIMENTAL
Intervention: Positive expectations
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Neutral expectations
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Negative expectations
Number of subjects: 83
Study: 28715298

Group type: EXPERIMENTAL
Intervention: High velocity low amplitude (HVLA) manipulation by practitioners with different seniority
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High velocity low amplitude (HVLA) manipulation
Number of subjects: 20
Study: 25381047

Group type: EXPERIMENTAL
Intervention: Zoledronate (ZOL) 4 mg intravenous every 3 months for 24 months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (PLB)
Number of subjects: 70
Study: 24018055

Group type: EXPERIMENTAL
Intervention: Outpatient care (intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inpatient care (usual care)
Number of subjects: 0
Study: 21291447

Group type: EXPERIMENTAL
Intervention: Chicago School Readiness Project (CSRP)
Number of subjects: 602
Study: 19805441

Group type: EXPERIMENTAL
Intervention: Interferon beta 1b
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Glatiramer acetate
Number of subjects: 74
Study: 16711171

Group type: EXPERIMENTAL
Intervention: Self‐adherent soft silicone dressing (Mepiform)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Left‐alone management (Control)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Soft silicone dressing (Mepiform)
Number of subjects: 11
Study: 15658645

Group type: EXPERIMENTAL
Intervention: Tongguan capsule (TGC) with Western medicine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Western medicine alone
Number of subjects: 52
Study: 11320886

Group type: EXPERIMENTAL
Intervention: Combined preoperative radiochemotherapy with hyperthermia (Radiotherapy: 5 x 1.8 Gy up to 45 Gy; Chemotherapy: 5-Fluorouracil 300-350 mg/m2/d and Leucovorin 50 mg; Hyperthermia: SIGMA 60 applicator BSD 2000 once a week).
Number of subjects: 0
Study: 9400557

Group type: EXPERIMENTAL
Intervention: Low ankle-arm index (AAI < or = .9) in participants without clinical CVD at baseline.
Number of subjects: 1537
Study: 7942624

Group type: EXPERIMENTAL
Intervention: cICAM-1 concentration in acute hepatitis
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: cICAM-1 concentration in mild chronic liver disease
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: cICAM-1 concentration in cirrhosis
Number of subjects: 135

Group type: COMPARATOR
Intervention: cICAM-1 concentration in extrahepatic diseases
Number of subjects: 135

Group type: COMPARATOR
Intervention: cICAM-1 concentration in healthy blood donors
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Total bilirubin
Number of subjects: 135
Study: 30706488

Group type: EXPERIMENTAL
Intervention: Kiwifruit (two kiwifruits twice daily for 3 days)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Kiwifruit
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (isocaloric maltodextrin, twice daily for 3 days)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study: 29222719

Group type: EXPERIMENTAL
Intervention: Transcorneal Electrical Stimulation (TES)
Number of subjects: 3
Study: 27241687

Group type: EXPERIMENTAL
Intervention: Building Bridges to Fatherhood program
Number of subjects: 180

Group type: COMPARATOR
Intervention: Financial literacy comparison condition
Number of subjects: 180
Study: 24888429

Group type: EXPERIMENTAL
Intervention: Isometric handgrip group (IHG) during 1 min of coronary balloon occlusion
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Isometric handgrip training (IHT) group performing 3 months of IHT
Number of subjects: 74

Group type: COMPARATOR
Intervention: Non-exercise group (NEG)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Non-training group (NTG)
Number of subjects: 74
Study: 22981147

Group type: EXPERIMENTAL
Intervention: LB80380 maleate formulation (183 mg tablet)
Number of subjects: 32

Group type: COMPARATOR
Intervention: LB80380 free base formulation (60 and 90 mg tablets)
Number of subjects: 32
Study: 20207328

Group type: EXPERIMENTAL
Intervention: Guided imagery with relaxation (GIR)
Number of subjects: 30
Study: 17888191

Group type: EXPERIMENTAL
Intervention: 0.75 mg kg(‐1) propofol followed by 8% sevoflurane
Number of subjects: 38

Group type: COMPARATOR
Intervention: 8% sevoflurane alone
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study: 15944536

Group type: EXPERIMENTAL
Intervention: Modified N-13 ammonia model
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional N-13 ammonia model
Number of subjects: 12

Group type: COMPARATOR
Intervention: O-15 water
Number of subjects: 12
Study: 14649346

Group type: EXPERIMENTAL
Intervention: Tramadol 1 mg kg(‐1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Meperidine 1 mg kg(‐1)
Number of subjects: 50
Study: 10067708

Group type: EXPERIMENTAL
Intervention: HIV vaccine candidates (e.g., live preparations, DNA plasmids)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General recommendations for trial design and analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mathematical models and trial simulations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternative methods for sample size calculations
Number of subjects: 0
Study: 8612313

Group type: EXPERIMENTAL
Intervention: Uracil plus ftorafur (UFT) at 350 mg/m2 plus leucovorin (150 mg daily)
Number of subjects: 8
Study: 2017582

Group type: EXPERIMENTAL
Intervention: 4-hour didactic and interactive teaching session on decision analysis
Number of subjects: 68

Group type: COMPARATOR
Intervention: 4-hour interactive session on a nondecision analysis topic
Number of subjects: 68
Study: 6129143

Group type: COMPARATOR
Intervention: Nomifensine
Number of subjects: 12

Group type: COMPARATOR
Intervention: HOE 8476
Number of subjects: 12

Group type: COMPARATOR
Intervention: Clobazam
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 12
Study: 29757489

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (early discharge)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 114
Study: 27824252

Group type: EXPERIMENTAL
Intervention: Body-weight neuromuscular training
Number of subjects: 28
Study: 24525393

Group type: EXPERIMENTAL
Intervention: Paracetamol 1 g twice daily for 12 weeks
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo twice daily for 12 weeks
Number of subjects: 94
Study: 22105813

Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg/d)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 20484944

Group type: EXPERIMENTAL
Intervention: Placement of water coolers in canteens
Number of subjects: 5866
Study: 17509174

Group type: EXPERIMENTAL
Intervention: GBV-C positive
Number of subjects: 272

Group type: COMPARATOR
Intervention: GBV-C negative
Number of subjects: 272
Study: 16126306

Group type: EXPERIMENTAL
Intervention: Low energy density gruel (G1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High energy density gruel (G2)
Number of subjects: 30
Study: 12116830

Group type: EXPERIMENTAL
Intervention: Modified transthecal digital block
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Subcutaneous digital block
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination of modified transthecal and subcutaneous digital block
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (traditional ring block)
Number of subjects: 30
Study: 10378908

Group type: EXPERIMENTAL
Intervention: Regular physical activity (supervised training, 3 times per week for 45 minutes over 6 months)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 51
Study: 7771838

Group type: EXPERIMENTAL
Intervention: Open venous reservoir system (ORS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Closed reservoir system
Number of subjects: 20
Study: 2181630

Group type: EXPERIMENTAL
Intervention: Amoxicillin (7 days)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Bacampicillin (7 days)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Enoxacin (7 days)
Number of subjects: 70
Study: 85538

Group type: EXPERIMENTAL
Intervention: Acoustic stimuli (tones) at 3 intensities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual stimuli (light flashes) at 3 intensities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acoustic stimuli (tones) at 3 rates of presentation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual stimuli (light flashes) at 3 rates of presentation
Number of subjects: 0
Study: 31400933

Group type: EXPERIMENTAL
Intervention: PGC preparation
Number of subjects: 18
Study: 29844209

Group type: EXPERIMENTAL
Intervention: Nebulizer with HFNC
Number of subjects: 6

Group type: COMPARATOR
Intervention: Jet nebulizer
Number of subjects: 6
Study: 27241835

Group type: EXPERIMENTAL
Intervention: 7.5 frames per second (f/s)
Number of subjects: 39

Group type: COMPARATOR
Intervention: 15 frames per second (f/s)
Number of subjects: 39
Study: 24948695

Group type: EXPERIMENTAL
Intervention: Rapid diagnostic tests
Number of subjects: 5794

Group type: COMPARATOR
Intervention: Clinical diagnosis
Number of subjects: 5794

Group type: COMPARATOR
Intervention: Microscopy
Number of subjects: 5794
Study: 22511495

Group type: EXPERIMENTAL
Intervention: High-dose imatinib (800 mg/day for 6 months) followed by standard-dose imatinib (400 mg/day)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Standard-dose imatinib (400 mg/day)
Number of subjects: 227
Study: 20547287

Group type: EXPERIMENTAL
Intervention: STI-positive adolescents who received treatment and counseling
Number of subjects: 636

Group type: COMPARATOR
Intervention: STI-negative adolescents who received no further intervention
Number of subjects: 636
Study: 17977537

Group type: EXPERIMENTAL
Intervention: 150 mg of ferrous sulfate daily
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study: 16096286

Group type: EXPERIMENTAL
Intervention: Lidcombe programme of early stuttering intervention
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study: 12684807

Group type: EXPERIMENTAL
Intervention: Higher physical activity levels (more time in sporting activities)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Lower physical activity levels (less time in sporting activities)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Active females
Number of subjects: 256

Group type: COMPARATOR
Intervention: Hypoactive females
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 256

Group type: COMPARATOR
Intervention: Girls
Number of subjects: 256
Study: 11374853

Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimal medical therapy including aggressive lipid control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coronary artery revascularization
Number of subjects: 0
Study: 8792265

Group type: EXPERIMENTAL
Intervention: Pivotal Response Training (PRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individual Target Behaviors (ITB)
Number of subjects: 0
Study: 1448776

Group type: EXPERIMENTAL
Intervention: Recombinate (recombinant FVIII preparation)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Hemofil M (high‐purity plasma‐derived concentrate)
Number of subjects: 47
Study: 3893238

Group type: EXPERIMENTAL
Intervention: Calcium chloride
Number of subjects: 73

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 73
Study: 31107920

Group type: EXPERIMENTAL
Intervention: Auditory temporal training activities
Number of subjects: 25

Group type: COMPARATOR
Intervention: Passive visual activities (placebo)
Number of subjects: 25
Study: 28351354

Group type: EXPERIMENTAL
Intervention: Case management group (met with a case manager at least three times over 12 months)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Case management group
Number of subjects: 95
Study: 26277934

Group type: EXPERIMENTAL
Intervention: Divided Attention (DA) during encoding with semantically related distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Divided Attention (DA) during encoding with semantically unrelated distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Divided Attention (DA) during retrieval with semantically related distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Divided Attention (DA) during retrieval with semantically unrelated distractors
Number of subjects: 0
Study: 25116967

Group type: EXPERIMENTAL
Intervention: Calcitriol ointment (3 mcg/g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Betamethasone diproprionate ointment (64 mg/g)
Number of subjects: 10
Study: 21756141

Group type: EXPERIMENTAL
Intervention: Non-hydrolized carnosine (Can-C Plus® formulation)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 19218618

Group type: EXPERIMENTAL
Intervention: Pelli‐Robson charts for contrast sensitivity measurement
Number of subjects: 107
Study: 17444139

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 15774778

Group type: EXPERIMENTAL
Intervention: Short-term preoperative radiotherapy (5 x 5 Gy)
Number of subjects: 990
Study: 12199663

Group type: EXPERIMENTAL
Intervention: Quantitative risk information (numerical and graphical presentation)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Qualitative risk information (verbal phrases)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Quantitative risk information
Number of subjects: 198

Group type: COMPARATOR
Intervention: Qualitative risk information
Number of subjects: 198
Study: 9445122

Group type: EXPERIMENTAL
Intervention: Radical systematic mediastinal lymphadenectomy (LA)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Mediastinal lymph node sampling (LS)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Radical systematic mediastinal lymphadenectomy (LA) in patients with limited lymph node involvement (pN1 or pN2 with involvement of only one lymph node level)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Radical systematic mediastinal lymphadenectomy (LA) in patients with pN0 disease
Number of subjects: 169
Study: 8704439

Group type: EXPERIMENTAL
Intervention: Longevity-Antihypertensive-Mixture (LAM)
Number of subjects: 302
Study: 2234840

Group type: EXPERIMENTAL
Intervention: Argon green (514 nm) modified grid laser photocoagulation
Number of subjects: 132

Group type: COMPARATOR
Intervention: Krypton red (647 nm) modified grid laser photocoagulation
Number of subjects: 132
Study: 699507

Group type: EXPERIMENTAL
Intervention: 3% CO2
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 6% CO2
Number of subjects: 10

Group type: COMPARATOR
Intervention: Air (Control)
Number of subjects: 10
Study: 31903600

Group type: EXPERIMENTAL
Intervention: Continuous transversus abdominis plane (TAP) block
Number of subjects: 180

Group type: COMPARATOR
Intervention: Combined general-thoracic epidural anaesthesia (TEA)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard general anaesthesia (GA)
Number of subjects: 180
Study: 30642326

Group type: EXPERIMENTAL
Intervention: Supervised physical exercise programme (2 weekly sessions for 6 months, including at least 30 min of moderate intensity activity)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Antidepressant drug treatment (habitually used in clinical practice)
Number of subjects: 312
Study: 27856208

Group type: EXPERIMENTAL
Intervention: Allogeneic hMSCs
Number of subjects: 37

Group type: COMPARATOR
Intervention: Autologous hMSCs
Number of subjects: 37
Study: 25572025

Group type: EXPERIMENTAL
Intervention: Second-generation everolimus-eluting stents (EES)
Number of subjects: 625

Group type: COMPARATOR
Intervention: First-generation sirolimus-eluting stents (SES)
Number of subjects: 625
Study: 25030489

Group type: EXPERIMENTAL
Intervention: Distraction cards
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Kaleidoscope
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 188
Study: 23085365

Group type: EXPERIMENTAL
Intervention: GMZ2 vaccine in Trichuris trichiura negative subjects
Number of subjects: 20

Group type: COMPARATOR
Intervention: GMZ2 vaccine in Trichuris trichiura positive subjects
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Memory B-cell response in T. trichiura negative individuals
Number of subjects: 20

Group type: COMPARATOR
Intervention: Memory B-cell response in T. trichiura positive individuals
Number of subjects: 20
Study: 20518324

Group type: EXPERIMENTAL
Intervention: JEV-L
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: JEV-I (Vero)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: JEV-I (PHK)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Comparison of JEV-I (Vero) vs JEV-I (PHK)
Number of subjects: 12
Study: 17301848

Group type: EXPERIMENTAL
Intervention: Photorefractive keratectomy
Number of subjects: 60
Study: 15342892

Group type: EXPERIMENTAL
Intervention: Healthy Start Program (HSP)
Number of subjects: 643
Study: 11232608

Group type: COMPARATOR
Intervention: VVI‐ICD
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: DDD‐ICD
Number of subjects: 92
Study: 9844981

Group type: EXPERIMENTAL
Intervention: Tourette syndrome with comorbidity (N = 23)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Tourette syndrome without comorbidity (N = 23)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Tourette syndrome with severe symptoms (N = 23)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Tourette syndrome with fewer and less severe symptoms (N = 23)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (N = 22)
Number of subjects: 46
Study: 7926296

Group type: EXPERIMENTAL
Intervention: Transition to microalbuminuria
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Nonprogressors
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 65
Study: 2689255

Group type: EXPERIMENTAL
Intervention: trimoprostil 750 micrograms taken 4 times daily
Number of subjects: 44

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 44
Study: 6108128

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (0.25‐0.50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triazolam (0.25‐0.50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brotizolam (0.6 mg)
Number of subjects: 0
Study: 29939239

Group type: EXPERIMENTAL
Intervention: Training and support programme
Number of subjects: 12

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 12
Study: 28741429

Group type: EXPERIMENTAL
Intervention: Zolmitriptan delivered via Adhesive Dermally‐Applied Microarray (ADAM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Zolmitriptan via ADAM
Number of subjects: 20
Study: 26001033

Group type: EXPERIMENTAL
Intervention: Regional Anesthesia (RA)
Number of subjects: 722

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 722